Zydus Cadila has the drug regulator’s emergency use authorisation to manage its Covid vaccine, ZyCoV-D, in kids aged 12-18 years. As Covaxin is about to change into accessible for a similar age group as effectively, the bargaining place of the federal government will enhance, as negotiations are underway with Zydus concerning the value of the vaccine.
“Whereas the federal government had mentioned that the Zydus vaccine will likely be added to the vaccination programme in October, negotiations are nonetheless not over,” mentioned a authorities official. An individual within the know mentioned Zydus Cadila has quoted lower than ₹300 for a single dose of its vaccine. Nonetheless, this worth would not embrace the value of the pharmaJet, which is required to manage the vaccine.
The pharmaJet, a needle-free applicator for painless intradermal vaccine supply, has been imported by Ahmedabad-based Zydus Cadila.
“It is an costly gadget and therefore jacks up the general worth of the vaccine,” the federal government official mentioned. The pharmaJet penetrates the cell membrane. Every jet delivers a certain quantity of the vaccine. So, a single dose is unfold into two pictures throughout two arms.
The jet injector can be utilized for administering round 20,000 doses.
The federal government has been shopping for Covaxin at ₹225 a dose and the opposite India-made Covid vaccine, Covishield, at ₹215.
Well being secretary Rajesh Bhushan had earlier mentioned the value of the Zydus Cadila vaccine could be fairly totally different from the present vaccines.